Find clinical trials for COVID-19 in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Seattle, WA, USA:
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Seattle, Washington, United States and 123 other locations
study is to determine if the study drug baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID...
Phase 3
Tacoma, Washington, United States and 19 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Seattle, Washington, United States and 214 other locations
an immunotherapy containing Natural Killer (NK) cells derived from human placental CD34+ cells and culture-expanded, in patients with moderate COVID...
Phase 1, Phase 2
Tacoma, Washington, United States and 6 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Seattle, Washington, United States and 59 other locations
This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechani...
Phase 2, Phase 3
Seattle, Washington, United States and 30 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
Seattle, Washington, United States and 35 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Seattle, Washington, United States and 114 other locations
the chances of contracting coronavirus disease 2019 (COVID-19) or developing a severe form of COVID-19 disease i...
Phase 2
Seattle, Washington, United States and 3 other locations
This is Phase 1 study is to assess tolerability and immunogenicity of three dose levels of the investigational HDT-301 vaccine administered intramusc...
Phase 1
Renton, Washington, United States
Clinical trials
Research sites
Resources
Legal